Andy Cothrel is President of Rushlight Ventures, where he is focused on monetizing the IP of small to mid-sized aerospace & defense firms, as well as spinning up and curating commercially-oriented new companies leveraging de-risked technology portfolios.  He is also active as a founder, investor, and/or board member to a number of early-stage companies.

Prior to Rushlight, he founded Blue Marble Medical, where he spent 13 years developing and commercializing medical/health technologies and consulting in strategy, M&A, and new product development & commercialization, from both BigCo and Startup perspectives. He has led seven startups, transacted four exits, and raised in excess of $60MM at various companies in various roles.

His initial 20-year corporate career spanned progressively responsible roles at Exxon, Abbott Labs, and Roche, where he ended his BigCo days as VP/Site Manager of Roche’s life sciences research business area and a corporate officer for the North American operating entity. His academic background is a BS and MS in mechanical engineering complemented by business education and University of Michigan, Cranfield University, and London Business School. He resides in Oakwood OH.